Navigation Links
Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study
Date:3/12/2009

A Phase II Study Published in The Lancet of Fast-Tracked Antiplatelet Agent Showed No Increase in TIMI Major and Minor Bleeding and was Well Tolerated When Given With Standard Platelet Therapy

KENILWORTH, N.J., March 12 /PRNewswire-FirstCall/ -- Results of a Schering-Plough Corporation (NYSE: SGP) Phase II trial of SCH 530348, a novel oral thrombin receptor antagonist (TRA), were published today in The Lancet and demonstrated that the investigational antiplatelet compound met its primary endpoints of safety and tolerability. TRA showed no increase in major and minor Thrombolysis in Myocardial Infarction (TIMI)-scale bleeding when given with current standard antiplatelet therapy (aspirin and clopidogrel) for patients undergoing percutaneous coronary intervention (PCI), commonly known as balloon angioplasty with stenting.

"The results of this study are encouraging as they support the viability of TRA as a potential new antiplatelet therapy option," said Richard Becker, MD, director of the Duke Cardiovascular Thrombosis Center and lead author of the study. "TRA appears to work in a novel way that is complementary to current antiplatelet therapies," he further commented.

Another important result from the Thrombin Receptor Antagonist Percutaneous Coronary Intervention (TRA-PCI) trial was the rate of thrombin-receptor agonist peptide (TRAP)-induced platelet aggregation inhibition, a secondary endpoint. Thrombin is the most potent platelet activator, which leads to platelet aggregation and the development of blood clots. In the study, TRA showed a much higher TRAP-induced platelet aggregation inhibition compared to standard of care alone in both loading and maintenance doses.

"In this study, TRA, when given with aspirin and clopidogrel, was able to inhibit the aggregation of platelets even when
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410
2. Daiichi Sankyo Initiates Phase III Trial of Its Investigational Factor Xa Inhibitor, DU-176b, in Patients With Atrial Fibrillation
3. Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial
4. Miami Jewish Home and Hospital, Berma Research Group and Segal Institute for Clinical Research Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimers Disease
5. Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting
6. Medarex Receives Milestone Payment for Investigational Antibody Targeting Integrin Receptors
7. Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008
8. Sequella Presents Data on Synergy Between Investigational New TB Drugs SQ109 and TMC207
9. Sequoia Pharmaceuticals Presents In Vitro and First-in-Human Data Supporting Further Development of SPI-256, a Novel Investigational Protease Inhibitor
10. Millennium Presents New Data on Investigational Drugs for Novel Cancer Targets at EORTC-NCI-AACR Symposium
11. Berlin Hearts EXCOR(R) Pediatric Receives Unconditional Investigational Device Exemption (IDE) Approval
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 21, 2013  NxStage Medical, Inc. (Nasdaq: ... today announced that it has entered into new agreements ... products to DaVita, the kidney care division of DaVita Healthcare ... For the use of products for home ... NxStage has executed a second amended and restated National ...
(Date:5/21/2013)... N.Y., May 21, 2013  Lakeland Industries, Inc. ... manufacturer of industrial protective clothing for industry, municipalities, ... and local levels, today announced that the Company ... a Senior Credit Facility subject to certain terms ... this financing.  However, no assurances can be given ...
(Date:5/21/2013)... mayo de 2013 La junta directiva ... incluyen OMNIlife science®, Inc., Enztec, Ltd. y Praxim, SA, ... junta. Guy Mayer, un ejecutivo ortopédico experimentado, será vicepresidente ... Johnson , un experto refutado en dispositivos ... de unirse a OSI como presidente de la ...
Breaking Medicine Technology:NxStage Announces New Agreements with DaVita 2Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 2Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 3Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 4Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 5Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 6Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 7Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 8Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 9Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 10Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 11Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 12Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results 13Orthopaedic Synergy, Inc. anuncia nuevas incorporaciones a la junta directiva 2Orthopaedic Synergy, Inc. anuncia nuevas incorporaciones a la junta directiva 3
(Date:5/21/2013)... transformation on a large scale is the cornerstone ... achieving better outcomes, better value and better experience ... the patient-centered medical home model offers a viable ... Department of Health and Human Services, Agency for ... learn more about the processes and determinants of ...
(Date:5/21/2013)... Mecklenburg EMS Agency (Medic) and the YMCA ... Fair to educate the public on health initiatives and provide ... May 22, 2013 from 4:00 pm until 7:00 pm at ... Road, Charlotte, NC 29262). , Medic, the Y, ... County Department of Social Services are working toward a ...
(Date:5/21/2013)... Paris, France: The Orsiro stent, which is a ... polymer, demonstrated non-inferiority to the Xience Prime everolimus-eluting ... late lumen loss at nine months in the ... 2013 today. , The BIOFLOW-II substudy used intravascular ... quantitatively assess neointimal hyperplasia and stent apposition at ...
(Date:5/21/2013)... The In View series , ... cable channels across the country, announces it has posted ... The producers of the series proudly bring audiences across ... the manufacturing industry, health-related companies, medical facilities and more. ... practitioners in all parts of the United States, Canada ...
(Date:5/21/2013)... MedMar Healing Center announces their participation ... Food Bank. Twenty-eight businesses, including MedMar Healing Center, doctors, and ... The goal is to raise food to help area kids ... families in recent years. , “We like being able ... need,” explains Douglas Chloupek of MedMar Healing Center. “Taking part ...
Breaking Medicine News(10 mins):Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 2Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 3Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 4Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 5Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 6Health News:Mecklenburg EMS Agency Teams Up with the YMCA of Greater Charlotte and Others to Educate the Public on Health Related Initiatives 2Health News:Biodegradable stent proves non-inferior to drug-eluting stent 2Health News:In View hosted by Larry King Announces New Videos on its YouTube Channel 2Health News:San Jose Cannabis Club Helps Feed Hungry Children with Second Harvest Food Bank 2
... Epstein-Barr virus (EBV) infects nine out of ten people ... early childhood often cause no disease symptoms, but people ... mononucleosis, a disease characterized by swollen lymph nodes, fever ... kinds of cancer, including Hodgkin lymphoma and stomach and ...
... , WEDNESDAY, Nov. 2 (HealthDay News) -- Although ... 15," most only put on between 2.5 to 3.5 pounds ... And, the researchers noted, this weight gain is typical ... "The ,freshman 15, is a media myth," study co-author ...
... Pittsburgh innovations that has moved from the lab to ... resulting in 105 licenses or options to industry and ... commercialization activity also included 37 U.S. patents that were ... of 257 new invention disclosures by Pitt faculty, according ...
... TUESDAY, Nov. 1 (HealthDay News) -- Folks genetically predisposed to ... by staying physically active, a new study suggests. A ... mass and obesity associated" (FTO) gene, which is known to ... effect on physically active adults compared to inactive ones. Their ...
... 2 (HealthDay News) -- Nearly half of 50 hospital ... a multidrug-resistant bacteria, a new study says. University ... baumannii (MDR-AB) bacteria on multiple surfaces, including bedrails, ... which has caused infection outbreaks in health care facilities ...
... in common? Perhaps more than meets the eye, according to ... A diverse group of scientists experts in cardiology, neurology, ... drugs that show promise in the treatment of dementia for ... In this case, the connection between the head and the ...
Cached Medicine News:Health News:NIH scientists outline steps toward Epstein-Barr virus vaccine 2Health News:No Such Thing as the 'Freshman 15,' Study Finds 2Health News:Two tech companies launched through Pitt research in 2011 2Health News:Exercise Might Help Thwart 'Obesity Gene' 2Health News:Hospital Rooms Crawling With Drug-Resistant Germs: Study 2Health News:Scientists explore whether what heals the head can also heal the heart 2Health News:Scientists explore whether what heals the head can also heal the heart 3
... xenon illumination for High ... instruments. Port allows use ... cables. Worldwide voltage and ... change drawer Infinite ...
... is so bright many surgeons turn it down ... shift into when the going gets tough. More ... true Hot Start and the technologically advanced fan ... prevent failed start ups and overheating. The result ...
... start circuit extends life of lamp Reserve lamp ... model allows simultaneous use with a reserve lamp ... unit cool.Worldwide voltage and electrical certification Lamp ... lamp Easy access to lamp for quick ...
... Lawson Lite positions directly over one,eye ... the lens an exclusive feature ... fiber optic light that penetrates,deep into ... universal swivel mount enables the,surgeon to ...
Medicine Products: